If you’re asking whether a peptide can repair your gut, the honest first answer is that no peptide is established as the best choice for it. The names you’ll see most are BPC-157, KPV and larazotide. BPC-157 and KPV are two of six peptides that HHS has just addressed in a new policy, and larazotide is not on that list. AP reports that most of the data on peptides comes from animal studies, and FDA staff reviewers concluded there was a lack of evidence on BPC-157 for ulcerative colitis. Here is what each source says, what the policy covers, and what to check before you pay.
What is this peptide policy, and what is it not?
The policy is an HHS Federal Register notice on the HHS policy, published October 30, 2026, with comments closing November 13, 2026. It names six peptides: BPC-157, TB-500, epitalon, Semax, KPV and MOTS-c. HHS says it “does not intend to take enforcement action against a State-licensed pharmacy, Federal facility, or licensed physician compounding a drug product using a bulk drug substance in Appendix A, in the circumstances the policy lists.” That is the whole of what it does. It tells pharmacies and prescribers what HHS will not pursue under stated conditions.
Enforcement discretion is not FDA approval. LegitScript, a third-party certification organization, summarizes the policy’s FAQ as saying that enforcement discretion “does not constitute FDA approval or establish that the compounded products are safe or effective.” The policy also does not add these peptides to the FDA’s bulks list. HHS says it may revisit the policy “in whole or in part” if a safety signal or product quality issue arises.
The HHS policy text and LegitScript’s policy explainer are the two documents to read if you want the conditions in full. For a plain reading, the next sections walk through them.
Who may fit, and who should pause?
The policy is written for prescriptions. It covers compounding that uses a patient-specific prescription, through a state-licensed pharmacy, a federal facility or a licensed physician. Its conditions also require one active ingredient, FDA-registered sourcing with a valid certificate of analysis, and a label that reads “This is a compounded drug product. Not for resale.”
LegitScript reads the policy as covering only single-ingredient products, so combinations such as BPC-157 with TB-500 or semaglutide fall outside it. If you take other medicines, ask a pharmacist or clinician which of them matter for you before you go further.
How do these peptides work in the gut?
The clearest research on peptides and the gut is about the body’s own antimicrobial peptides, not the lab-made ones sold online. A 2021 review in 2021 review of antimicrobial peptides describes these as having an anti-inflammatory response and “promoting epithelial damage repair.” The same review says “research on the application of AMPs is incomplete and controversial.” A 2023 2023 review on gut antimicrobial peptides states that “the complete mechanism is not well understood.”
Those reviews describe the body’s own peptides. They do not describe how BPC-157 or KPV works in a gut. Ask the seller which mechanism it claims and which study it points to for that claim.
What does the research show?
Established facts
- FDA staff scientists “unanimously opposed every peptide being added to the list, citing a lack of solid clinical trial data, inconsistent recipes from batch to batch and the risk the compounds could trigger harmful immune reactions,” according to ABC News on the FDA advisers vote.
- The advisory committee that voted in July recommended the six peptides, and ABC News reports the vote was narrow. Its recommendations are not binding.
- FDA briefing materials said there was a “lack of evidence to make a conclusion on the effectiveness of BPC-157” for ulcerative colitis, as reported by The Hill on FDA briefing materials.
- AP reports that most of the data on peptides comes from animal studies, in its AP report on the peptide plan.
What sellers say
AP describes BPC-157 as promoted to build muscle and heal injuries. Gut claims come from each seller’s own product page, so read the exact wording there and compare it with the study the seller names.
Our reading
Gut claims for these peptides run ahead of the human research you can point to. Treat each gut claim as a question for the seller rather than a result.
Open questions
- Which human study does the seller name, and how many people did it include?
- What did that study measure, and what result did it report?
- For an oral product, what documentation shows the specific formulation reaches adequate oral bioavailability in humans? The policy requires this, and a route alone is not enough.
What does it cost, and what is the total commitment?
Prices and bundles change, so check today’s price directly with the company before you pay. Ask the prescriber and the pharmacy for the full cost, including any visit, the medicine itself and any refills. Read the renewal and cancellation terms on the order page before you enter payment details.
What are the side effects and risks?
HHS states that compounded drugs “may pose risks to patients.” The risks named in the reporting below are the ones to raise with your clinician.
| Risk | What the source reports | Source |
|---|---|---|
| Contamination | Possible risk named by FDA for these injectable peptides | AP report on the peptide plan |
| Allergic reactions | Possible risk named by FDA | AP report on the peptide plan |
| Tumor growth | Possible risk named by FDA | AP report on the peptide plan |
| Harmful immune reactions | Cited by FDA scientists | ABC News on the FDA advisers vote |
| Batch-to-batch variation | FDA scientists cited “inconsistent recipes from batch to batch” | ABC News on the FDA advisers vote |
BPC-157 was placed in FDA’s list of risky bulk substances before this policy. Under the policy, serious adverse events and product quality issues must be reported to FDA and the relevant states.
Is the seller legit, and how do I check?
A seller’s legitimacy shows in its paperwork, not its ad. Run these checks before you give any payment details.
- Which peptide is it? Only the six in the policy, in the listed form and route, can fall under its conditions.
- Which kind of pharmacy? The policy excludes 503B outsourcing facilities. A 2016 article on 503A pharmacies describes them as regulated by the states, typically retail and hospital pharmacies.
- Is the pharmacy licensed where you live? The Partnership for Safe Medicines petition reports that five vials bought from telehealth services came from pharmacies licensed in Texas and Pennsylvania, and none of those businesses had licenses to dispense injectables in California. Ask whether the pharmacy holds a license to dispense injectables in your state.
- Is it sold as a research chemical or a supplement? The policy excludes products sold as research chemicals or dietary supplements, according to the BakerHostetler summary of the policy.
- Where is it advertised? AP reports these products “remain widely available for purchase via online platforms like TikTok.”
LegitScript says its certification “does not guarantee access to their services,” meaning advertising platforms and payment providers set their own rules. A seller’s certification is not a guarantee that its ads will run or its payments will process.
What are the alternatives, including approved options and doing nothing?
Approved options
ABC News notes that some peptides, such as insulin and GLP-1s, are “FDA-approved medicines that have been rigorously tested.” None of the six peptides in the policy is among them. For a gut problem, ask your clinician which FDA-approved treatments fit your situation.
Food and fiber
A common food-based option is prebiotic fiber. Cleveland Clinic on inulin fiber describes inulin as a prebiotic dietary fiber found in many foods you probably already eat. It lists constipation, cramping, diarrhea, gas and uncomfortable bloating as side effects of too much, and says artificial sources of inulin can aggravate conditions like irritable bowel syndrome. For food-first ideas, see digestive and oral health and whole foods are the best medicine.
Doing nothing, and doing it yourself
Doing nothing while you talk with a clinician is a real option. The policy names state-licensed pharmacies, federal facilities and licensed physicians, so there is no home version of it. For a wider view of the policy, the RFK Jr. peptide plan safety options article covers what the plan means for buyers.
Which questions settle the decision?
| Question | What the answer means |
|---|---|
| Is the peptide one of the six in the policy? | Yes: it can fall under the policy’s conditions. No: it sits outside the policy. |
| Is it in the listed form and route, such as BPC-157 acetate by mouth? | Yes: the route matches the policy’s list. No: the route falls outside it. |
| Is it a single ingredient? | Yes: it meets that condition. No: LegitScript reads combinations as failing it. |
| Is there a patient-specific prescription? | Yes: the prescription condition is met. No: it is missing. |
| Is it sold as a research chemical or a supplement? | Yes: the policy excludes it. No: it is a compounded product from a pharmacy. |
| Is the pharmacy a state-licensed 503A pharmacy? | Yes: it can fall within the policy. No: a 503B outsourcing facility is excluded. |
| Does it come with a certificate of analysis from an FDA-registered facility? | Yes: that condition is documented. No: ask for it before you pay. |
| Is the syringe an FDA 510(k)-cleared syringe? | Yes: the device condition is met. No: an injector pen does not meet it. |
| For an oral form, is there documentation of oral bioavailability in humans? | Yes: the oral condition is addressed. No: a route alone is not enough. |
How do I verify before I pay?
- Ask for the certificate of analysis and the manufacturer’s name, and check that the manufacturing site is FDA-registered.
- Check the label for the required wording: “This is a compounded drug product. Not for resale.”
- Confirm the pharmacy’s license for your state.
- Get the refund and renewal terms in writing from support before you pay.
- Ask how the seller reports serious adverse events and product quality issues.
Check the Federal Register notice on the HHS policy for any revision, since HHS may change the policy.
Your remaining questions
Is BPC-157 good for your gut?
The Hill reports that FDA briefing materials concluded there was a lack of evidence to make a conclusion on the effectiveness of BPC-157 for ulcerative colitis. For gut repair, ask the seller for the named human study, its sample size and its results. For how long it takes to repair a gut, ask your prescriber what to expect and over what period. Treat any timeline a seller gives as a claim to check against a study. For inflammation, ask the seller which human study it points to for an anti-inflammatory effect and what that study measured.
What about KPV?
KPV is one of the six peptides in the policy, covered in topical and oral forms. FDA staff reached the same conclusion for all six peptides, according to The Hill on FDA briefing materials: there was not enough evidence to support adding any of them to the compoundable list. For a gut claim on KPV, ask the seller for its study.
What has been studied in people?
Ask any seller for the named trial, its sample size, what it measured and the result. For a deeper look at how these trials are read, see what peptides trials found (our research library). Larazotide is not one of the six peptides in the policy, so the policy’s conditions do not apply to it. Ask for its trial details the same way.
Are there FDA-approved options for gut problems?
Ask your clinician which FDA-approved treatments fit your situation. The approved options are the ones with FDA review of their safety and effectiveness, which the policy notes compounded drugs do not have.
Peptides for gut health and weight loss
If a seller ties a peptide to weight loss, ask for the human study behind that specific claim. For what any public figure takes, the reliable answer is that person’s own statement, so check the episode or their own channel rather than an ad.
Questions to ask your clinician
- Is a prescription for one of these six peptides appropriate for my gut problem, and what other options fit?
- Which of my current medicines could interact with a peptide?
- What side effects should I watch for, and where should I report them?
- What should I expect, and over what period?
- Are there FDA-approved treatments for my condition?
For a broader look at peptides, read peptides safety evidence (our research library), which covers the research on safety.
By Gut, Gum and Nail Health Editorial Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.